Navigation Links
Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults
Date:9/12/2007

g people from all walks of life, ages, and gender. Parents, families and friends need to discuss with teens and young adults the ramifications that opioid dependence can have on their lives," continued Dr. Menestrina. "Given the rising prevalence of opioid painkiller misuse demonstrated by SAMHSA's data, I would urge every doctor, especially the family doctors who are on the front line of healthcare delivery, to screen their patients for this chronic brain disease and to become certified to treat those who are opioid dependent with Suboxone(R), an FDA-approved medication that allows treatment in a physician's office. This office-based treatment allows opioid dependence to be medically managed with the same privacy and patient confidentiality that we accord any other serious medical condition."

Resources for Opioid Dependence and Its Treatment

Individuals who need more information about opioid dependence and its treatment, either for themselves or for someone they are concerned about, have several options.

Visit TurnToHelp.com or call 1-866-455-TURN for a free educational Resource kit on opioid dependence and the treatments that are available for it, both provided by Reckitt Benckiser Pharmaceuticals, Inc.

The Addiction411 page on MySpace offers direct access to information about this increasingly prevalent disease and practical guidance on how to find treatment for opioid dependence. Visit http://www.myspace.com/addiction411 if you or someone you know would like to access Addiction411.

NAABT, a non-profit patient advocacy group -- National Alliance of Advocates for Buprenorphine Treatment -- is dedicated to helping educate the public on opioid dependence and treatment in a private doctor's office. NAABT offers a confidential nationwide matching service to pair individuals seeking buprenorphine treatment with available area physicians; visit '/>"/>

SOURCE Reckitt Benckiser Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Researchers Developing Office-Based Cancer Screening Test
2. Check if your “Favourite medical web-site” is indulging in Quackey
3. Teens turning to Internet for medical queries
4. Robots craft medical history
5. NBE to conduct test for medical students from abroad
6. Air pollution combined with greater medical needs
7. Indian Nationals with Foreign Medical Degrees can now practice in India
8. Children! Protecting them from medical mistakes
9. More information sought by patients on medical errors
10. SARS necessitates medical masks
11. Meditation Works Medically
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
(Date:12/4/2009)Whether the H1N1 virus will come back during winter isn,t known, CDC says, , , FRIDAY, Dec. 4 (HealthDay News) -- The number of states reporting widespread swine flu activity continued to decl
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Are angry women more like men? 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Swine Flu Continues to Wane 2
... a.m. ET -, EMERYVILLE, Calif., Feb. 11 Neurobio... ) today announced financial,results for its fisca...2007., Revenues for the second quarter of 2007 we...Dec. 31, 2007 versus,$5.7 million in the same peri...
...wo Little Hands Productions --,creators of the pop...ision,show designed to teach babies, toddlers and ...Language (ASL) -- will debut its second season at ... series two will continue building children,s ASL,...
...ew Solution to Increase Customer Revenues, Manage ...SE: MSY.L), the global application software and se...istan has gone live with Misys,Equation. The solut...th the bank,s 2008 strategy focused on sustaining ...
... Irvine Hires Agency for Public Relations, MISSIO...,today announces it now provides public relations ...gan in December 2007 on Web site mapping and,messa... the past year, and we,anticipate many more change...
...1 Kay Renz Public Relations,has been retained by ...ts,Peter G. Ballas MD, who has a thriving practice...highly regarded nationally as one of the foremost,...ducts. He is currently introducing Artefill (R), t...
...tes Dblur,s Software Lens(TM) Technology Into its ...YA, Israel, February 11 Dblur, the developer of,S...ategic cooperation with,STMicroelectronics (NYSE: ...The product portfolio should include a 3.2Mp, 1.75...
Other Medicine News:Health News:Neurobiological Technologies Reports Second Quarter Financial Results 2Health News:Neurobiological Technologies Reports Second Quarter Financial Results 3Health News:Neurobiological Technologies Reports Second Quarter Financial Results 4Health News:Neurobiological Technologies Reports Second Quarter Financial Results 5Health News:Two Little Hands Productions, Creators of Popular Children's TV Series Signing Time, Debuts Second Season at This Year's Toy Fair 2008 2Health News:Mybank Goes Live With Misys Equation to Support Rapid Growth and Meet Future Regulatory Requirements 2Health News:St. Conti Communications to Help Adjust Chiropractor Messaging and Communications 2Health News:Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line 2Health News:Dblur Concludes Licensing Deal With STMicroelectronics 2
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)Opposes use of imported drugs often stored in tin cans and car trunks ,, WASHINGTON, Dec. 4 Today, the senior advocacy group RetireSafe urged the Senate to defeat the Dorgan Importation plan encomp
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 1ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 2ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 3ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 4The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 1The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 2The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 3The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 4The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 5The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 6The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 7The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 8The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 9The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 10The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 11The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 12Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 1Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 2Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 3Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 4Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 5Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 6Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 7Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 8Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 9Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 10Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor 28TNF 29 Blockers 53670 11
...K--(BUSINESS WIRE)--May 29, 2007 - Pfizer said tod...types of cancer, such as,melanoma, thyroid, liver,... renal cell carcinoma (RCC) - a type of advanced k...American Society of,Clinical Oncology (ASCO) annua...sponds differently to treatment, so,it,s critical ...
...--(BUSINESS WIRE)--May 29, 2007 - Mitopharm Corpor...ts of a research paper,where Professor Dr. Robert ... B, the precursor of (-) Schisandrin B - a novel,d...n a research paper entitled "SCHISANDRIN B PROTECT...Y ENHANCING MYOCARDIAL,GLUTATHIONE ANTIOXIDANT STA...
Other Medicine Technology:New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 2New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 3New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 4New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 5Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 2Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 3
High Lite Convertible
High Lite Classic
High Beam Classic
...nalyzer is a semi-automated benchtop instrument fo...nQuick is designed to analyze and generate results...k 8+ urine test strips. The UrinQuick analyzes the...y. Test results are available in conventional, S.I...
Medicine Products: